$ENZN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ENZON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ENZON PHARMACEUTICALS, INC.. Get notifications about new insider transactions in ENZON PHARMACEUTICALS, INC. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17 2020 | ENZN | ENZON PHARMACEUTIC ... | Bleznick Jordan | Director | Buy | P | 0.15 | 100,000 | 15,380 | 100,000 | 0 to 100 K |
| Nov 17 2020 | ENZN | ENZON PHARMACEUTIC ... | Bleznick Jordan | Director | Buy | P | 0.15 | 100,000 | 15,380 | 100,000 | 0 to 100 K |
| Oct 14 2020 | ENZN | ENZON PHARMACEUTIC ... | ICAHN CARL C | 10% Owner | Option Exercise | X | 1,090.00 | 39,277 | 42,811,930 | 0 | |
| Oct 14 2020 | ENZN | ENZON PHARMACEUTIC ... | ICAHN CARL C | 10% Owner | Buy | X | 0.00 | 39,277 | 0 | 39,277 | 0 to 39.3 K |
| Oct 14 2020 | ENZN | ENZON PHARMACEUTIC ... | ICAHN CARL C | 10% Owner | Buy | X | 0.00 | 29,457,750 | 0 | 36,056,636 | 6.6 M to 36.1 M (+446.40 %) |
| Aug 26 2020 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Sell | S | 0.19 | 25,000 | 4,783 | 1,590,194 | 1.6 M to 1.6 M (-1.55 %) |
| Aug 26 2020 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Sell | S | 0.18 | 52,100 | 9,555 | 1,615,194 | 1.7 M to 1.6 M (-3.12 %) |
| Mar 27 2020 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.14 | 160,785 | 22,510 | 633,264 | 472.5 K to 633.3 K (+34.03 %) |
| Mar 27 2020 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.14 | 469,551 | 65,737 | 472,479 | 2.9 K to 472.5 K (+16,036.58 %) |
| Mar 27 2020 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.14 | 2,678 | 375 | 2,928 | 250 to 2.9 K (+1,071.20 %) |
| Mar 27 2020 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.14 | 19,709 | 2,661 | 1,594,232 | 1.6 M to 1.6 M (+1.25 %) |
| Feb 14 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.25 | 5,000 | 1,250 | 1,574,523 | 1.6 M to 1.6 M (+0.32 %) |
| Feb 14 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.25 | 10,000 | 2,500 | 1,569,523 | 1.6 M to 1.6 M (+0.64 %) |
| Feb 14 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.25 | 10,000 | 2,500 | 4,717,666 | 4.7 M to 4.7 M (+0.21 %) |
| Feb 14 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.25 | 500 | 125 | 4,707,666 | 4.7 M to 4.7 M (+0.01 %) |
| Feb 14 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.25 | 10,000 | 2,500 | 4,707,166 | 4.7 M to 4.7 M (+0.21 %) |
| Feb 14 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.25 | 15,500 | 3,875 | 4,697,166 | 4.7 M to 4.7 M (+0.33 %) |
| Feb 14 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.25 | 5,000 | 1,250 | 1,574,523 | 1.6 M to 1.6 M (+0.32 %) |
| Feb 14 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.25 | 10,000 | 2,500 | 1,569,523 | 1.6 M to 1.6 M (+0.64 %) |
| Feb 14 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.25 | 10,000 | 2,500 | 4,717,666 | 4.7 M to 4.7 M (+0.21 %) |
| Feb 14 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.25 | 500 | 125 | 4,707,666 | 4.7 M to 4.7 M (+0.01 %) |
| Feb 14 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.25 | 10,000 | 2,500 | 4,707,166 | 4.7 M to 4.7 M (+0.21 %) |
| Feb 14 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.25 | 15,500 | 3,875 | 4,697,166 | 4.7 M to 4.7 M (+0.33 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 2,000 | 510 | 4,681,666 | 4.7 M to 4.7 M (+0.04 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 2,500 | 638 | 4,679,666 | 4.7 M to 4.7 M (+0.05 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 4,500 | 1,148 | 4,677,166 | 4.7 M to 4.7 M (+0.10 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.27 | 312,523 | 84,100 | 1,559,523 | 1.2 M to 1.6 M (+25.06 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.24 | 213,189 | 50,419 | 1,247,000 | 1 M to 1.2 M (+20.62 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.23 | 15,261 | 3,510 | 1,033,811 | 1 M to 1 M (+1.50 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.22 | 2,500 | 550 | 1,018,550 | 1 M to 1 M (+0.25 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.22 | 1,100 | 242 | 1,016,050 | 1 M to 1 M (+0.11 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.22 | 450 | 99 | 1,014,950 | 1 M to 1 M (+0.04 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.22 | 42,450 | 9,339 | 1,014,500 | 972.1 K to 1 M (+4.37 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.22 | 40,050 | 8,811 | 972,050 | 932 K to 972.1 K (+4.30 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.22 | 15,000 | 3,294 | 932,000 | 917 K to 932 K (+1.64 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.21 | 2,500 | 525 | 917,000 | 914.5 K to 917 K (+0.27 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.21 | 100,000 | 21,000 | 914,500 | 814.5 K to 914.5 K (+12.28 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.21 | 100,000 | 21,000 | 814,500 | 714.5 K to 814.5 K (+14.00 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 67,200 | 17,472 | 4,672,666 | 4.6 M to 4.7 M (+1.46 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 8,800 | 2,277 | 4,605,466 | 4.6 M to 4.6 M (+0.19 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 20,600 | 5,253 | 4,596,666 | 4.6 M to 4.6 M (+0.45 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 3,671 | 936 | 4,576,066 | 4.6 M to 4.6 M (+0.08 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 384,100 | 98,906 | 4,572,395 | 4.2 M to 4.6 M (+9.17 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 9,500 | 2,470 | 4,188,295 | 4.2 M to 4.2 M (+0.23 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 40,316 | 10,482 | 4,178,795 | 4.1 M to 4.2 M (+0.97 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 8,255 | 2,146 | 4,138,479 | 4.1 M to 4.1 M (+0.20 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 112 | 29 | 4,130,224 | 4.1 M to 4.1 M (0.00 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 26,655 | 6,930 | 4,130,112 | 4.1 M to 4.1 M (+0.65 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 11,368 | 2,956 | 4,103,457 | 4.1 M to 4.1 M (+0.28 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 355 | 92 | 4,092,089 | 4.1 M to 4.1 M (+0.01 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 635 | 165 | 4,091,734 | 4.1 M to 4.1 M (+0.02 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 2,800 | 728 | 4,091,099 | 4.1 M to 4.1 M (+0.07 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 21,975 | 5,714 | 4,088,299 | 4.1 M to 4.1 M (+0.54 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 20,000 | 5,200 | 4,066,324 | 4 M to 4.1 M (+0.49 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 600 | 156 | 4,046,324 | 4 M to 4 M (+0.01 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 1,300 | 338 | 4,045,724 | 4 M to 4 M (+0.03 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 32,345 | 8,410 | 4,044,424 | 4 M to 4 M (+0.81 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 1,120 | 291 | 4,012,079 | 4 M to 4 M (+0.03 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 500 | 130 | 4,010,959 | 4 M to 4 M (+0.01 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 68,195 | 17,731 | 4,010,459 | 3.9 M to 4 M (+1.73 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 2,000 | 520 | 3,942,264 | 3.9 M to 3.9 M (+0.05 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 2,000 | 510 | 4,681,666 | 4.7 M to 4.7 M (+0.04 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 1,000 | 260 | 3,940,264 | 3.9 M to 3.9 M (+0.03 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 2,500 | 638 | 4,679,666 | 4.7 M to 4.7 M (+0.05 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 5,500 | 1,430 | 3,939,264 | 3.9 M to 3.9 M (+0.14 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 4,500 | 1,148 | 4,677,166 | 4.7 M to 4.7 M (+0.10 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 50,000 | 13,000 | 3,933,764 | 3.9 M to 3.9 M (+1.29 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.27 | 312,523 | 84,100 | 1,559,523 | 1.2 M to 1.6 M (+25.06 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 20,200 | 5,252 | 3,883,764 | 3.9 M to 3.9 M (+0.52 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.24 | 213,189 | 50,419 | 1,247,000 | 1 M to 1.2 M (+20.62 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 4,000 | 1,040 | 3,863,564 | 3.9 M to 3.9 M (+0.10 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.23 | 15,261 | 3,510 | 1,033,811 | 1 M to 1 M (+1.50 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 55,000 | 14,300 | 3,859,564 | 3.8 M to 3.9 M (+1.45 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.22 | 2,500 | 550 | 1,018,550 | 1 M to 1 M (+0.25 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 33,500 | 8,710 | 3,804,564 | 3.8 M to 3.8 M (+0.89 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.22 | 1,100 | 242 | 1,016,050 | 1 M to 1 M (+0.11 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 3,000 | 780 | 3,771,064 | 3.8 M to 3.8 M (+0.08 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.22 | 450 | 99 | 1,014,950 | 1 M to 1 M (+0.04 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 185,700 | 48,282 | 3,768,064 | 3.6 M to 3.8 M (+5.18 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.22 | 42,450 | 9,339 | 1,014,500 | 972.1 K to 1 M (+4.37 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 4,700 | 1,222 | 3,582,364 | 3.6 M to 3.6 M (+0.13 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.22 | 40,050 | 8,811 | 972,050 | 932 K to 972.1 K (+4.30 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.22 | 15,000 | 3,294 | 932,000 | 917 K to 932 K (+1.64 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.21 | 2,500 | 525 | 917,000 | 914.5 K to 917 K (+0.27 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.21 | 100,000 | 21,000 | 914,500 | 814.5 K to 914.5 K (+12.28 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.21 | 100,000 | 21,000 | 814,500 | 714.5 K to 814.5 K (+14.00 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 67,200 | 17,472 | 4,672,666 | 4.6 M to 4.7 M (+1.46 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 8,800 | 2,277 | 4,605,466 | 4.6 M to 4.6 M (+0.19 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 20,600 | 5,253 | 4,596,666 | 4.6 M to 4.6 M (+0.45 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 3,671 | 936 | 4,576,066 | 4.6 M to 4.6 M (+0.08 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 384,100 | 98,906 | 4,572,395 | 4.2 M to 4.6 M (+9.17 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 9,500 | 2,470 | 4,188,295 | 4.2 M to 4.2 M (+0.23 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 40,316 | 10,482 | 4,178,795 | 4.1 M to 4.2 M (+0.97 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 8,255 | 2,146 | 4,138,479 | 4.1 M to 4.1 M (+0.20 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 112 | 29 | 4,130,224 | 4.1 M to 4.1 M (0.00 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 26,655 | 6,930 | 4,130,112 | 4.1 M to 4.1 M (+0.65 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 11,368 | 2,956 | 4,103,457 | 4.1 M to 4.1 M (+0.28 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 355 | 92 | 4,092,089 | 4.1 M to 4.1 M (+0.01 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 635 | 165 | 4,091,734 | 4.1 M to 4.1 M (+0.02 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 2,800 | 728 | 4,091,099 | 4.1 M to 4.1 M (+0.07 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 21,975 | 5,714 | 4,088,299 | 4.1 M to 4.1 M (+0.54 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 20,000 | 5,200 | 4,066,324 | 4 M to 4.1 M (+0.49 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 600 | 156 | 4,046,324 | 4 M to 4 M (+0.01 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 1,300 | 338 | 4,045,724 | 4 M to 4 M (+0.03 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 32,345 | 8,410 | 4,044,424 | 4 M to 4 M (+0.81 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 1,120 | 291 | 4,012,079 | 4 M to 4 M (+0.03 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 500 | 130 | 4,010,959 | 4 M to 4 M (+0.01 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 68,195 | 17,731 | 4,010,459 | 3.9 M to 4 M (+1.73 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 2,000 | 520 | 3,942,264 | 3.9 M to 3.9 M (+0.05 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 1,000 | 260 | 3,940,264 | 3.9 M to 3.9 M (+0.03 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 5,500 | 1,430 | 3,939,264 | 3.9 M to 3.9 M (+0.14 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 50,000 | 13,000 | 3,933,764 | 3.9 M to 3.9 M (+1.29 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 20,200 | 5,252 | 3,883,764 | 3.9 M to 3.9 M (+0.52 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 4,000 | 1,040 | 3,863,564 | 3.9 M to 3.9 M (+0.10 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 55,000 | 14,300 | 3,859,564 | 3.8 M to 3.9 M (+1.45 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 33,500 | 8,710 | 3,804,564 | 3.8 M to 3.8 M (+0.89 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 3,000 | 780 | 3,771,064 | 3.8 M to 3.8 M (+0.08 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 185,700 | 48,282 | 3,768,064 | 3.6 M to 3.8 M (+5.18 %) |
| Jan 09 2019 | ENZN | ENZON PHARMACEUTIC ... | COUCHMAN JONATHAN | 10% Owner | Buy | P | 0.26 | 4,700 | 1,222 | 3,582,364 | 3.6 M to 3.6 M (+0.13 %) |
| Nov 29 2016 | ENZN | ENZON PHARMACEUTIC ... | ICAHN CARL C | 10% Owner | Option Exercise | H | 1.09 | 1 | 1 | 0 | |
| Nov 29 2016 | ENZN | ENZON PHARMACEUTIC ... | ICAHN CARL C | 10% Owner | Buy | P | 0.41 | 694,023 | 281,079 | 6,598,886 | 5.9 M to 6.6 M (+11.75 %) |
| Sep 19 2013 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Sell | S | 1.69 | 21,119 | 35,626 | 42,189 | 63.3 K to 42.2 K (-33.36 %) |
| Sep 19 2013 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Sell | S | 1.74 | 34,807 | 60,456 | 63,308 | 98.1 K to 63.3 K (-35.48 %) |
| Jan 25 2013 | ENZN | ENZON PHARMACEUTIC ... | Rackear Andrew D. | VP and General Coun ... | Grant | A | 0.00 | 4,686 | 0 | 78,019 | 73.3 K to 78 K (+6.39 %) |
| Jan 25 2013 | ENZN | ENZON PHARMACEUTIC ... | Buchbinder Aby | VP, Clinical Develo ... | Grant | A | 0.00 | 3,748 | 0 | 79,246 | 75.5 K to 79.2 K (+4.96 %) |
| Jan 25 2013 | ENZN | ENZON PHARMACEUTIC ... | Conover Charles | SVP, R&D Program Ma ... | Grant | A | 0.00 | 2,343 | 0 | 74,793 | 72.5 K to 74.8 K (+3.23 %) |
| Jan 04 2013 | ENZN | ENZON PHARMACEUTIC ... | Young Richard A | Director | Option Exercise | A | 4.54 | 20,129 | 91,386 | 20,129 | |
| Jan 04 2013 | ENZN | ENZON PHARMACEUTIC ... | Deuel Thomas | Director | Option Exercise | A | 4.54 | 20,129 | 91,386 | 20,129 | |
| Jan 04 2013 | ENZN | ENZON PHARMACEUTIC ... | SALISBURY ROBERT C | Director | Option Exercise | A | 4.54 | 20,129 | 91,386 | 20,129 | |
| Jan 04 2013 | ENZN | ENZON PHARMACEUTIC ... | Mulligan Richard | Director | Option Exercise | A | 4.54 | 35,226 | 159,926 | 35,226 | |
| Jan 04 2013 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Option Exercise | A | 4.54 | 20,129 | 91,386 | 20,129 | |
| Jan 04 2013 | ENZN | ENZON PHARMACEUTIC ... | DENNER ALEXANDER J | Director | Option Exercise | A | 4.54 | 40,258 | 182,771 | 40,258 | |
| Nov 08 2012 | ENZN | ENZON PHARMACEUTIC ... | HEBARD GEORGE | Interim PEO and Int ... | Option Exercise | A | 6.18 | 73,500 | 454,230 | 73,500 | |
| Nov 08 2012 | ENZN | ENZON PHARMACEUTIC ... | HEBARD GEORGE | Interim PEO and Int ... | Grant | A | 0.00 | 24,500 | 0 | 43,237 | 18.7 K to 43.2 K (+130.76 %) |
| Jul 03 2012 | ENZN | ENZON PHARMACEUTIC ... | SALISBURY ROBERT C | Director | Grant | A | 0.00 | 10,669 | 0 | 67,707 | 57 K to 67.7 K (+18.71 %) |
| Aug 15 2012 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Sell | S | 6.58 | 5,820 | 38,308 | 98,115 | 103.9 K to 98.1 K (-5.60 %) |
| Aug 13 2012 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Sell | S | 6.58 | 1,933 | 12,720 | 103,935 | 105.9 K to 103.9 K (-1.83 %) |
| Jul 03 2012 | ENZN | ENZON PHARMACEUTIC ... | Young Richard A | Director | Grant | A | 0.00 | 10,669 | 0 | 30,231 | 19.6 K to 30.2 K (+54.54 %) |
| Jul 03 2012 | ENZN | ENZON PHARMACEUTIC ... | LEBUHN ROBERT | Director | Grant | A | 0.00 | 10,669 | 0 | 105,868 | 95.2 K to 105.9 K (+11.21 %) |
| Jul 03 2012 | ENZN | ENZON PHARMACEUTIC ... | Deuel Thomas | Director | Grant | A | 0.00 | 10,669 | 0 | 32,231 | 21.6 K to 32.2 K (+49.48 %) |
| Jul 03 2012 | ENZN | ENZON PHARMACEUTIC ... | Mulligan Richard | Director | Grant | A | 0.00 | 18,670 | 0 | 49,064 | 30.4 K to 49.1 K (+61.43 %) |
| Jul 03 2012 | ENZN | ENZON PHARMACEUTIC ... | DENNER ALEXANDER J | Director | Grant | A | 0.00 | 21,338 | 0 | 60,620 | 39.3 K to 60.6 K (+54.32 %) |
| Jun 21 2012 | ENZN | ENZON PHARMACEUTIC ... | HEBARD GEORGE | Interim PEO and Int ... | Buy | P | 6.88 | 5,000 | 34,395 | 18,737 | 13.7 K to 18.7 K (+36.40 %) |
| Jun 06 2012 | ENZN | ENZON PHARMACEUTIC ... | Rackear Andrew D. | VP and General Coun ... | Sell | S | 6.81 | 1,614 | 10,983 | 56,720 | 58.3 K to 56.7 K (-2.77 %) |
| Jun 06 2012 | ENZN | ENZON PHARMACEUTIC ... | Conover Charles | SVP, R&D Program Ma ... | Sell | S | 6.78 | 25,000 | 169,500 | 57,213 | 82.2 K to 57.2 K (-30.41 %) |
| Mar 29 2012 | ENZN | ENZON PHARMACEUTIC ... | Daly Timothy | VP, Controller and ... | Grant | A | 0.00 | 8,000 | 0 | 8,000 | 0 to 8 K |
| Mar 16 2012 | ENZN | ENZON PHARMACEUTIC ... | Young Richard A | Director | Sell | S | 6.92 | 2,000 | 13,842 | 19,562 | 21.6 K to 19.6 K (-9.28 %) |
| Jan 19 2012 | ENZN | ENZON PHARMACEUTIC ... | Buchbinder Aby | VP, Clinical Develo ... | Option Exercise | A | 6.69 | 12,000 | 80,280 | 12,000 | |
| Jan 19 2012 | ENZN | ENZON PHARMACEUTIC ... | Buchbinder Aby | VP, Clinical Develo ... | Grant | A | 0.00 | 4,000 | 0 | 58,015 | 54 K to 58 K (+7.41 %) |
| Feb 29 2012 | ENZN | ENZON PHARMACEUTIC ... | HEBARD GEORGE | Director | Option Exercise | A | 7.28 | 10,297 | 74,962 | 10,297 |